Crunching the numbers for MRK... Refresh in a moment for the full analysis.
Merck & Co., Inc. (MRK)
Healthcare
Deep Overvalued
mixed
$122.84
Updated: 2026-04-12
58
TradeApes Score
hold
Financial Strength
55
Mixed
Operating Trend
58
Mixed
Valuation
55
Mixed
Capital Allocation
55
Mixed
Risk
80
Strong
Fair Value
$0.0
Sector Rank
#16
of 18
Key Findings
+
Solid revenue growth — sales up 8–20% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.